Evidence map›Paper›PMID 33955170›Full record

Trial reportJournal of the International AIDS Society2021

A cluster-randomized controlled trial of a combination HIV risk reduction and microfinance intervention for female sex workers who use drugs in Kazakhstan.

Nabila El-Bassel, Tara McCrimmon, Gaukhar Mergenova, Mingway Chang, Assel Terlikbayeva, Sholpan Primbetova, Azamat Kuskulov, Bauyrzhan Baiserkin, Alfiya Denebayeva, Kulpan Kurmetova and 1 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the International AIDS Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. "Protected Means Armed": Perspectives on Pre-Exposure Prophylaxis (PrEP) Among Women Who Engage in Sex Work and Use Drugs in Kazakhstan.AIDS education and prevention : official publication of the International Society for AIDS Education · 2023
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Nabila El-BasselGlobal Health Research Center of Central Asia, Columbia University School of Social Work, New York, NY, USA.
Tara McCrimmonGlobal Health Research Center of Central Asia, Columbia University School of Social Work, New York, NY, USA.ORCID 0000-0002-9090-3785
Gaukhar MergenovaGlobal Health Research Central Asia, Almaty, Kazakhstan.
Mingway ChangGlobal Health Research Center of Central Asia, Columbia University School of Social Work, New York, NY, USA.
Assel TerlikbayevaGlobal Health Research Central Asia, Almaty, Kazakhstan.
Sholpan PrimbetovaGlobal Health Research Central Asia, Almaty, Kazakhstan.
Azamat KuskulovGlobal Health Research Central Asia, Almaty, Kazakhstan.
Bauyrzhan BaiserkinKazakh Scientific Center for Dermatology and Infectious Diseases, Almaty, Kazakhstan.
Alfiya DenebayevaAlmaty City Center of the Prevention and Control of AIDS, Almaty, Kazakhstan.
Kulpan KurmetovaTemirtau Branch, Karaganda Oblast Center for the Prevention and Control of AIDS, Temirtau, Kazakhstan.
Susan S WitteGlobal Health Research Center of Central Asia, Columbia University School of Social Work, New York, NY, USA.
Global Health Research Center of Central Asia · USGlobal Health Research Center of Central Asia · KZAlmaty Management University · KZKaraganda State Industrial University · KZKazakh Scientific Research Veterinary Institute · KZ

Funding

Training Program on HIV and Substance Use in the Criminal Justice SystemT32DA037801 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Nabila El-Bassel, Lisa R Metsch · 2014 to 2026
$5.7M
Evaluating a Microfinance Intervention for High Risk Women in KazakhstanR01DA036514 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI EL-BASSEL, NABILA, WITTE, SUSAN S · 2014 to 2018
$3.5M
NIDA NIH HHS R01 DA036514NIDA NIH HHS T32 DA037801
6 · The paper itself

Abstract

introductionFemale sex workers (FSW) who use drugs are a key population at risk of HIV in Kazakhstan, and face multiple structural barriers to HIV prevention. More research is needed on the role of structural interventions such as microfinance (MF) in reducing HIV risk. This paper describes the results of a cluster-randomized controlled trial to test the efficacy of a combination HIVRR + MF intervention in reducing biologically confirmed STIs and HIV risk behaviours.

methodsThis study took place from May 2015 to October 2018 in two cities in Kazakhstan. We screened 763 participants for eligibility and enrolled 354 FSW who use drugs. Participants were randomized in cohorts to receive either a four-session HIVRR intervention, or that same intervention plus 30 additional sessions of financial literacy training, vocational training and asset-building through a matched-savings programme. Repeated behavioural and biological assessments were conducted at baseline, 3-, 6- and 12-months post-intervention. Biological and behavioural primary outcomes included HIV/STI incidence, sexual risk behaviours and drug use risk behaviours, evaluated over the 12-month period.

resultsOver the 12-month follow-up period, few differences in study outcomes were noted between arms. There was only one newly-detected HIV case, and study arms did not significantly differ on any STI incidence. At post-intervention assessments compared to baseline, both HIVRR and HIVRR + MF participants significantly reduced sexual and drug use risk behaviours, and showed improvements in financial outcomes, condom use attitudes and self-efficacy, social support, and access to medical care. In addition, HIVRR + MF participants showed a 72% greater reduction in the number of unprotected sex acts with paying partners at the six-month assessment (IRR = IRR = 0.28, 95% CI = 0.08, 0.92), and a 10% greater reduction in the proportion of income from sex work at the three-month assessment (b = -0.10, 95% CI = -0.17, -0.02) than HIVRR participants did. HIVRR + MF participants also showed significantly improved performance on financial self-efficacy compared to HIVRR over the 12-month follow-up period.

conclusionsCompared to a combination HIVRR + MF intervention, a robust HIVRR intervention alone may be sufficient to reduce sexual and drug risk behaviours among FSW who use drugs. There may be structural limitations to the promise of microfinance for HIV risk reduction among this population.

Indexed as

HIV InfectionsPharmaceutical PreparationsSexually Transmitted DiseasesSex WorkersFemaleHumansKazakhstanRisk Reduction BehaviorPharmaceutical Preparationsclinical trialsdrug useHIV preventionsex workersstructural interventions

Identifiers

PMID33955170
PMCPMC8100396
OpenAlexW3159110619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.